An interesting article by Moran and others published in The Lancet Infectious Diseases August 16th discusses this issue. The management of patients presenting to healthcare service with SARS-CoV-2 infection has developed rapidly over the past year, driven by the...
Researchers published an article in Nature Aging 9th August 2021 which looked at the gut microbiota. Gut microbiota is increasingly recognised as an important regulator of host immunity and brain health. The aging process yields dramatic alterations in...
The MHRA has approved the UK’s first monoclonal antibody treatment for COVID-19. Regeneron/Roche’s Ronapreve binds to the virus in the lining of the respiratory system, blocking access to cells and can be administered either by injection or infusion. ...
An interesting paper published in the BMJ by Takeshita and others researched this issue. Although several studies have reported an association between atherosclerotic related diseases and COVID-19, the relationship between COVID-19 severity and...
An interesting paper by Yu and others sought to answer this question. A previous efficacy trial found benefit from inhaled budesonide for COVID-19 patients not admitted to hospital but effectiveness in high risk individuals is unknown. This...
An interesting abstract published in Wellcome Open research awaiting peer review looked into this issue. Red and others studied the behavioural response to SARS-CoV-2 antibody test results as part of the REACT study. This is a large community based...
